Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9562018
SERIAL NO

14655642

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine and pharmaceutically acceptable solvates thereof, preparation thereof, pharmaceutical compositions containing them and use of the same in the treatment and/or prevention of neurodegenerative diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITÉ DE LILLE42 RUE PAUL DUEZ LILLE 59800

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barrier, Mathieu Wavrin, FR 4 2
Buee, Luc Templemars, FR 12 21
Burlet, Stéphane Croix, FR 5 2
Estrella, Cécilia Lomme, FR 5 2
Melnyk, Patricia Annoeullin, FR 13 7
Sergeant, Nicolas Ronchin, FR 18 141
Verwaerde, Philippe Santes, FR 15 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00